It is a pharma private limited company based in Gandhinagar, Gujarat, India, established in 2014.
2014 | Gandhinagar, Gujarat, India | ActiveAvensis Pharmaceuticals Private Limited, a active private limited company, was established on 20 March 2014 in Gandhinagar, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230GJ2014PTC079251. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹2.00 M.
It upholds a compliant status. Its leadership includes Jagdishbhai Bhagwatbhai Desai (Director), Sanjaykumar Jitendrabhai Jha (Director). Past directors included Himanshu Shankerlal Patel, Sandeep Gupta, Abhinav Ashok Kumar Kansal. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No B/218 Electronic Estate, Sector No. 25, Gandhinagar, Gujarat, 382025.
U24230GJ2014PTC079251
079251
20 March 2014
₹5.00 M
₹2.00 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Avensis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jagdishbhai Bhagwatbhai Desai | Director | 20 Mar 2014 | Current |
| Sanjaykumar Jitendrabhai Jha | Director | 20 Mar 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Feb 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 26 Feb 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Avensis Pharmaceuticals Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 338.15% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.15%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Avensis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Avensis Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Avensis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avensis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Avensis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Avensis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
Progress on Jagdishbhai Bhagwatbhai Desai was appointed as a Director was appointed as a Director on 20 Mar 2014 & has been associated with this company since 11 years 8 months . was documented.
Progress on Sanjaykumar Jitendrabhai Jha was appointed as a Director was appointed as a Director on 20 Mar 2014 & has been associated with this company since 11 years 8 months . was documented.
The activity Avensis Pharmaceuticals Private Limited was registered on 20 Mar 2014 with Roc Ahmedabad & aged 11 years 8 months as per MCA records. was completed.
The CIN of Avensis Pharmaceuticals Private Limited is U24230GJ2014PTC079251.
Avensis Pharmaceuticals Private Limited is headquartered at Plot No B/218 Electronic Estate, Sector No. 25, Gandhinagar, Gujarat, 382025.
Avensis Pharmaceuticals Private Limited was incorporated on 20 March 2014.
The current directors of Avensis Pharmaceuticals Private Limited are
The primary industry of Avensis Pharmaceuticals Private Limited is Pharma.
Avensis Pharmaceuticals Private Limited is unlisted.
The authorized capital of Avensis Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹2.00 M.
The compliance status of Avensis Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX